TY - JOUR
KW - buprenorphine
KW - California State Targeted Response
KW - implementation
KW - opioid epidemic
KW - Opioid use disorder treatment
AU - G. M. Miele
AU - L. Caton
AU - T. E. Freese
AU - M. McGovern
AU - K. Darfler
AU - V. P. Antonini
AU - M. Perez
AU - R. Rawson
A1 - 
AD - University of California, Los Angeles Integrated Substance Abuse Programs, 11075 Santa Monica Blvd., #200, Los Angeles, CA 90025, United States of America; David Geffen School of Medicine at UCLA, 11075 Santa Monica Blvd., #200, Los Angeles, CA 90025, United States of America. Electronic address: gmiele@mednet.ucla.edu.; Stanford University School of Medicine, 1520 Page Mill Road, MC 5265, Palo Alto, CA 94304, United States of America. Electronic address: lauren.caton@stanford.edu.; University of California, Los Angeles Integrated Substance Abuse Programs, 11075 Santa Monica Blvd., #200, Los Angeles, CA 90025, United States of America; David Geffen School of Medicine at UCLA, 11075 Santa Monica Blvd., #200, Los Angeles, CA 90025, United States of America. Electronic address: tfreese@mednet.ucla.edu.; Stanford University School of Medicine, 1520 Page Mill Road, MC 5265, Palo Alto, CA 94304, United States of America. Electronic address: mpmcg@stanford.edu.; University of California, Los Angeles Integrated Substance Abuse Programs, 11075 Santa Monica Blvd., #200, Los Angeles, CA 90025, United States of America; David Geffen School of Medicine at UCLA, 11075 Santa Monica Blvd., #200, Los Angeles, CA 90025, United States of America. Electronic address: kdarfler@mednet.ucla.edu.; University of California, Los Angeles Integrated Substance Abuse Programs, 11075 Santa Monica Blvd., #200, Los Angeles, CA 90025, United States of America; David Geffen School of Medicine at UCLA, 11075 Santa Monica Blvd., #200, Los Angeles, CA 90025, United States of America. Electronic address: vpearce@mednet.ucla.edu.; California Department of Health Care Services, 1500 Capitol Ave, Sacramento, CA 95814, United States of America. Electronic address: marlies.perez@dhcs.ca.gov.; University of California, Los Angeles Integrated Substance Abuse Programs, 11075 Santa Monica Blvd., #200, Los Angeles, CA 90025, United States of America; David Geffen School of Medicine at UCLA, 11075 Santa (TRUNCATED)
BT - Journal of substance abuse treatment
C5 - Opioids & Substance Use
CY - United States
JF - Journal of substance abuse treatment
M1 - Journal Article
PB - Elsevier Inc
PP - United States
PY - 2020
SN - 1873-6483; 0740-5472
SP - 20
EP - 25
EP - 
T1 - Implementation of the hub and spoke model for opioid use disorders in California: Rationale, design and anticipated impact
T2 - Journal of substance abuse treatment
TI - Implementation of the hub and spoke model for opioid use disorders in California: Rationale, design and anticipated impact
U1 - Opioids & Substance Use
U2 - 31399272
VL - 108
VO - 1873-6483; 0740-5472
Y1 - 2020
Y2 - Jan
ER -